A key characteristic of the Group is its biotechnology engineering expertise. The ClonBio Engineering division works constantly to enhance the performance of the biorefinery and on the development of new biotech projects. Since commencing production in 2012, the biorefinery has undergone several expansions and has almost trebled in size. Engineering expertise has been central to the development of a state of the art facility. Continuous investment and innovation enabled annual gains of over 10 per cent in energy efficiency, yields and volumes.